High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients - PubMed (original) (raw)
. 1993 Apr 1;53(7):1625-9.
Affiliations
- PMID: 8453633
High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients
L Daya-Grosjean et al. Cancer Res. 1993.
Abstract
Xeroderma pigmentosum (XP) patients are clinically characterized by a very high incidence of skin cancers on exposed skin, at an early age. XP cells in vitro are strongly deficient in excision-repair and highly mutagenized by UV light. We were, therefore, interested in measuring mutation frequency and in determining mutation spectra in patients' tumors exposed to UV lesions. We chose to look at oncogene activation in skin tumors with the idea that more mutations, particularly of the ras gene family, would be found in XP tumors where lesions remain unrepaired compared to normal individuals. Our results clearly show that more than a 2-fold significantly higher mutation frequency (50%) of the ras genes was found in XP in contrast to control tumors (22%). The majority of the mutations were found at codon 12 of all three ras genes with a preponderance for N-ras in XP samples. The mutation spectra indicate that all mutations found were located opposite pyrimidine-pyrimidine sequences which represent a hot spot for UV-induced DNA lesions. Most of the mutations were of the type expected from studies performed in vitro with model systems. This high mutation frequency in XP was accompanied by a very high level of Ha-ras and c-myc gene amplification and rearrangement. All these data are consistent with a fundamental role of unrepaired UV-induced DNA lesions as an initiating event in human skin tumors on exposed parts of the body.
Similar articles
- Activated oncogenes in human skin tumors from a repair-deficient syndrome, xeroderma pigmentosum.
Suarez HG, Daya-Grosjean L, Schlaifer D, Nardeux P, Renault G, Bos JL, Sarasin A. Suarez HG, et al. Cancer Res. 1989 Mar 1;49(5):1223-8. Cancer Res. 1989. PMID: 2645047 - Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
Spatz A, Giglia-Mari G, Benhamou S, Sarasin A. Spatz A, et al. Cancer Res. 2001 Mar 15;61(6):2480-6. Cancer Res. 2001. PMID: 11289118 - The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors.
Daya-Grosjean L, Sarasin A. Daya-Grosjean L, et al. Mutat Res. 2005 Apr 1;571(1-2):43-56. doi: 10.1016/j.mrfmmm.2004.11.013. Epub 2005 Jan 25. Mutat Res. 2005. PMID: 15748637 Review. - p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
Giglia G, Dumaz N, Drougard C, Avril MF, Daya-Grosjean L, Sarasin A. Giglia G, et al. Cancer Res. 1998 Oct 1;58(19):4402-9. Cancer Res. 1998. PMID: 9766670 - TP53 mutations in human skin cancers.
Giglia-Mari G, Sarasin A. Giglia-Mari G, et al. Hum Mutat. 2003 Mar;21(3):217-28. doi: 10.1002/humu.10179. Hum Mutat. 2003. PMID: 12619107 Review.
Cited by
- The role of altered nucleotide excision repair and UVB-induced DNA damage in melanomagenesis.
Budden T, Bowden NA. Budden T, et al. Int J Mol Sci. 2013 Jan 9;14(1):1132-51. doi: 10.3390/ijms14011132. Int J Mol Sci. 2013. PMID: 23303275 Free PMC article. Review. - Unraveling cancer lineage drivers in squamous cell carcinomas.
Guan Y, Wang G, Fails D, Nagarajan P, Ge Y. Guan Y, et al. Pharmacol Ther. 2020 Feb;206:107448. doi: 10.1016/j.pharmthera.2019.107448. Epub 2019 Dec 11. Pharmacol Ther. 2020. PMID: 31836455 Free PMC article. Review. - Impact of the Circadian Clock on UV-Induced DNA Damage Response and Photocarcinogenesis.
Dakup P, Gaddameedhi S. Dakup P, et al. Photochem Photobiol. 2017 Jan;93(1):296-303. doi: 10.1111/php.12662. Epub 2016 Dec 18. Photochem Photobiol. 2017. PMID: 27861965 Free PMC article. Review. - Langerhans Cells Facilitate UVB-Induced Epidermal Carcinogenesis.
Lewis JM, Bürgler CD, Freudzon M, Golubets K, Gibson JF, Filler RB, Girardi M. Lewis JM, et al. J Invest Dermatol. 2015 Nov;135(11):2824-2833. doi: 10.1038/jid.2015.207. Epub 2015 Jun 8. J Invest Dermatol. 2015. PMID: 26053049 Free PMC article. - Elevated Levels of Soluble CTLA-4, PD-1, PD-L1, LAG-3 and TIM-3 and Systemic Inflammatory Stress as Potential Contributors to Immune Suppression and Generalized Tumorigenesis in a Cohort of South African Xeroderma Pigmentosum Patients.
Kgokolo MCM, Anderson K, Siwele SC, Steel HC, Kwofie LLI, Sathekge MM, Meyer PWA, Rapoport BL, Anderson R. Kgokolo MCM, et al. Front Oncol. 2022 Feb 11;12:819790. doi: 10.3389/fonc.2022.819790. eCollection 2022. Front Oncol. 2022. PMID: 35223501 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials
Miscellaneous